GLP & GMP Gap Analysis

Strengthening Compliance. Reducing Inspection Risk. Enabling Sustainable Readiness.

Pharada’s GMP & GLP Gap Analysis services provide a structured, inspection-focused evaluation of quality systems, laboratory practices, and operational controls against current regulatory expectations. Our approach goes beyond checklist compliance—identifying root causes, systemic weaknesses, and inspection-critical risks that impact regulatory outcomes and business continuity.

Our Approach

Pharada conducts GMP & GLP gap analyses using a regulatory inspection mindset. We assess systems, behaviors, documentation, and decision-making as an inspector would—focusing on data integrity, governance effectiveness, and operational robustness.

Our reviews are risk-based, evidence-driven, and practical, translating regulatory requirements into prioritized actions that strengthen compliance while supporting business objectives. We align findings with GMP/GLP principles, current inspection trends, and the organization’s maturity level.

The Challenge

Many organizations appear compliant on paper yet face recurring regulatory observations, delayed approvals, or inspection stress due to:

  • Fragmented or inconsistently implemented quality systems

  • Gaps between documented procedures and actual practices

  • Weak data integrity controls and laboratory governance

  • Reactive inspection preparation rather than sustained readiness

  • CAPA systems that address symptoms, not root causes

Without a clear, risk-based understanding of compliance gaps, organizations remain vulnerable to repeat findings and regulatory escalation.

Delivery Model

Services are delivered through a flexible and blended model, tailored to client needs:

  • On-site or remote assessments

  • Document-based and operational reviews

  • Single-site or multi-site evaluations

  • Short diagnostic reviews or full-system gap analyses

What We Deliver
  • Clear, structured gap analysis report aligned with GMP/GLP requirements

  • Risk-ranked findings with regulatory impact assessment

  • Practical, prioritized remediation roadmap

  • Executive-level summary highlighting inspection-critical risks

  • Actionable recommendations focused on sustainability—not quick fixes

Who This Is For
  • Pharmaceutical and life sciences manufacturers

  • Quality control and testing laboratories

  • Organizations preparing for regulatory inspections

  • Companies addressing warning letters or repeat observations

  • Management teams seeking objective, third-party compliance insight

Service Scope

Our GMP & GLP Gap Analysis services may include, depending on scope and regulatory context:

  • Comprehensive GMP or GLP compliance assessments

  • Laboratory and data integrity gap analysis

  • Quality Management System (QMS) effectiveness reviews

  • Inspection readiness and mock inspection exercises

  • Review of SOPs, records, and governance structures

  • Risk-based classification of findings (critical, major, other)

  • CAPA adequacy and sustainability evaluation